- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Zydus Lifesciences Limited — Updates, 22-01-2026: Press Release
22-01-2026 | 09:51 am
22-01-2026 | 09:51 am
Zydus launched 'Tishtha™', the world's first biosimilar of Nivolumab in India to treat multiple cancers. This makes advanced immunotherapy accessible by reducing treatment costs by ~75%, enhancing affordability for over 0.5 Cr patients.
No comments yet. Be the first to comment!